Pelish Henry E. (CIK 2029477) reported 63 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-13). Recent activity: Buy NUVL (3,093 shares), Sell NUVL (2,193 shares), Sell NUVL (900 shares), Sell NUVL (1,703 shares), Buy NUVL (1,754 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-13 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 3,093 | $86,140 |
| 2026-04-13 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 2,193 | $228,664 |
| 2026-04-13 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 900 | $94,500 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 1,703 | $169,806 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 1,754 | $48,849 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 4,125 | $120,986 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 2,985 | $215,965 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 24,189 | $2.4M |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 5,505 | $541,912 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 306 | $30,331 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 804 | $78,704 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 2,597 | $256,662 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 8,456 | $160,072 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 513 | $49,279 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 660 | $63,921 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 1,137 | $111,381 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 186 | $18,325 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 1,106 | $107,006 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 1,369 | $133,245 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 189 | $18,598 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 17,500 | $0 |
| 2025-12-23 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 5,085 | $5,492 |
| 2025-10-17 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 3,668 | $69,435 |
| 2025-10-17 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 7,495 | $208,736 |
| 2025-10-17 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 3,042 | $220,089 |
Source: SEC Form 4 filings · as of 2026-04-13